-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Pharma-Bio Serv, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2024.
- Pharma-Bio Serv, Inc. Operating Income (Loss) for the quarter ending January 31, 2025 was -$92.2K, a 79% increase year-over-year.
- Pharma-Bio Serv, Inc. Operating Income (Loss) for the twelve months ending January 31, 2025 was -$941K, a 369% decline year-over-year.
- Pharma-Bio Serv, Inc. annual Operating Income (Loss) for 2024 was -$1.29M, a 215% decline from 2023.
- Pharma-Bio Serv, Inc. annual Operating Income (Loss) for 2023 was $1.12M, a 4.9% decline from 2022.
- Pharma-Bio Serv, Inc. annual Operating Income (Loss) for 2022 was $1.17M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)